Dr. Ahilan has 35 years of experience in pharma industry having held Directorships in Pharmaceutical Sciences, Regulatory, Pharmacovigilance, Medical Affairs, QA and Global Manufacturing & Supply chain management. As a Director of Global operations and subsequently as a Consultant he has managed post-acquisition integration of product portfolios for listed companies as well as techno-commercial due diligence for potential mergers and acquisitions. His career includes working in industry for SmithKline Beecham, American Cyanamid, Wyeth-Ayerst and Goldshield (US & UK listings). Designated “Responsible Person” for Warehousing & Distribution by MHRA as well as a recognised Expert Report writer (CMC) for MA licensing and variation submissions. Dr Ahilan is also a BSi Qualified Lead Auditor and works on EU/UK GMP & GDP non-compliance remediation projects with companies being held to national enforcement action.
Cinmoy Dey has more than 20 years of experience in the Pharmaceutical Industry. He has worked as a Lead QP, Director of Quality/QP, Head of EU QP/RP Team, Technical Director for Quality, Regulatory Affair & PV in the UK and Ireland based multinational pharmaceutical companies. Cinmoy Dey is also a UK MHRA registered Qualified Person (QP), Responsible Person for Import (RPi), experienced Pharmaceutical Consultant, Lead Auditor and works on EU/UK GMP & GDP non-compliance remediation projects with the companies being held to national enforcement action. His career includes working in industry for Leo Pharma Ireland, Ranbaxy (now Sun Pharma) Ireland, Teva Ireland, Glenmark UK, B&S Group UK, Torrent Pharma UK, Perennial Pharma UK Etc.
Paresh has a pharmacy background and a stellar track record, spanning over 15 years in regulatory affairs and quality expertise. He is a highly experienced RA professional and worked predominantly CMC focused roles and has worked for several different company’s pharmaceuticals and medical devices across UK, Europe, the Middle East, Asia Pacific and USA markets.